Cargando…

Drastic antitumor response following administration of afatinib immediately after atezolizumab in a patient with epidermal growth factor receptor tyrosine kinase inhibitor‐resistant lung cancer

Detalles Bibliográficos
Autores principales:	Sumi, Toshiyuki, Nakata, Hisashi, Chiba, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Case Image
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258357/ https://www.ncbi.nlm.nih.gov/pubmed/34096184 http://dx.doi.org/10.1111/1759-7714.14047

Ejemplares similares

Long‐term response to afatinib in an elderly patient with uncommon epidermal growth factor receptor mutation‐positive lung adenocarcinoma
por: Shijubou, Naoki, et al.
Publicado: (2021)

Pseudomesotheliomatous carcinoma of lung adenocarcinoma diagnosed using transesophageal ultrasound‐guided bronchoscopic aspiration
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Diffuse alveolar haemorrhage due to pheochromocytoma crisis
por: Shijubou, Naoki, et al.
Publicado: (2021)

Unexpected haemorrhage from lateral thoracic artery following the removal of a pleural drainage tube
por: Matsuura, Keigo, et al.
Publicado: (2021)

Delayed local reaction at a previous injection site reaction with dupilumab
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Asymptomatic congenital tracheal stenosis
por: Sumi, Toshiyuki, et al.
Publicado: (2019)

Tegafur/gimeracil/oteracil‐induced eosinophilic pneumonia
por: Sumi, Toshiyuki, et al.
Publicado: (2020)

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
por: Nelson, Valerie, et al.
Publicado: (2013)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
por: Morin-Ben Abdallah, Sami, et al.
Publicado: (2017)

Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2017)

Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Successful management of severe bronchial asthma exacerbated by anti‐PD‐L1 treatment: A report of two cases
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Long‐term response to osimertinib in elderly patients with lung adenocarcinoma harbouring de novo EGFR T790M: a case report and literature review
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Severe heart failure due to peripartum cardiomyopathy
por: Michimata, Haruhiko, et al.
Publicado: (2023)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance
por: Creelan, Ben C., et al.
Publicado: (2019)

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer
por: Sano, Kazumi, et al.
Publicado: (2020)

A new solvate of afatinib, a specific inhibitor of the ErbB family of tyrosine kinases
por: Zeller, Matthias, et al.
Publicado: (2017)

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
por: Wu, Shang-Gin, et al.
Publicado: (2016)

An epidermal cyst in the areola
por: Yamaguchi, Toshiyuki
Publicado: (2022)

“Liquid elbows” due to afatinib administration
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Hemothorax as a complication of transbronchial lung cryobiopsy
por: Michimata, Haruhiko, et al.
Publicado: (2022)

Diffuse large B‐cell lymphoma with cardiac invasion diagnosed using transesophageal ultrasound‐guided bronchoscopic aspiration
por: Nagayama, Daiki, et al.
Publicado: (2022)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
por: Suga, Takayoshi, et al.
Publicado: (2023)

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2
por: Tanaka, Hidekazu, et al.
Publicado: (2014)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer
por: Liu, Bing, et al.
Publicado: (2016)

Spheroacanthocytes secondary to novel tyrosine kinase inhibitors
por: Ashby, Michael, et al.
Publicado: (2020)

Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Fulminant amebic colitis in a patient with concomitant cytomegalovirus infection after systemic steroid therapy: A case report
por: Shijubou, Naoki, et al.
Publicado: (2021)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance
por: Honeywell, Richard J., et al.
Publicado: (2020)

Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report
por: Sumi, Toshiyuki, et al.
Publicado: (2020)

Pseudocirrhosis due to liver metastasis from lung adenocarcinoma
por: Shijubou, Naoki, et al.
Publicado: (2021)

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations
por: Suzawa, Ken, et al.
Publicado: (2015)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
por: Nishiya, Naoyuki, et al.
Publicado: (2019)

Toxic epidermal necrosis associated with afatinib: A case report and literature review
por: Yang, Wei, et al.
Publicado: (2023)

Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
por: Zhang, Ningning, et al.
Publicado: (2019)

Epidermal Cyst on the Sole
por: Lee, Kyung Min, et al.
Publicado: (2013)

Immediate Lymphatic Reconstruction Drastically Lowers Lymphedema Incidence in Axillary and Inguinal Lymphadenectomy: A Systematic Review
por: Chun, Magnus, et al.
Publicado: (2021)

Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses
por: Wang, Hsian-Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vrrnjo0npam7r31is4vi3ck335